Atherosclerosis: The cost of illness in Portugal
| Autor: | Francisco Lourenço, Cristina Gavina, Alexandre Amaral‐Silva, Alberto Mello e Silva, Margarida Borges, João Costa, João Morais, Víctor Gil, Luís Mendes Pedro, Marta Ferreira Cardoso, Francisco Araújo, Manuel Teixeira Veríssimo, J. Alarcão, António Vaz-Carneiro, F Fiorentino, R. Ascenção, Daniel Caldeira, Manuel Correia, Miguel Gouveia |
|---|---|
| Přispěvatelé: | Repositório da Universidade de Lisboa |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Aterosclerose Portugal business.industry Atherosclerosis Custos de cuidados de saúde Hospitalization Indirect costs Direct costs Custo da doença RC666-701 medicine Cost of illness Humans General Earth and Planetary Sciences Diseases of the circulatory (Cardiovascular) system Custos indiretos Health Expenditures Health care costs Custos diretos Intensive care medicine business General Environmental Science |
| Zdroj: | Revista Portuguesa de Cardiologia (English Edition), Vol 40, Iss 6, Pp 409-419 (2021) Repositório Científico de Acesso Aberto de Portugal Repositório Científico de Acesso Aberto de Portugal (RCAAP) instacron:RCAAP |
| ISSN: | 2174-2049 |
| Popis: | Copyright © 2020 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. All rights reserved. © 2020 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa ̃na, S.L.U. This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Introduction and objectives: Cardiovascular disease is the leading cause of death in Portugal and atherosclerosis is the most common underlying pathophysiological process. The aim of this study was to quantify the economic impact of atherosclerosis in Portugal by estimating disease-related costs. Methods: Costs were estimated based on a prevalence approach and following a societal perspective. Three national epidemiological sources were used to estimate the prevalence of the main clinical manifestations of atherosclerosis. The annual costs of atherosclerosis included both direct costs (resource consumption) and indirect costs (impact on population productivity). These costs were estimated for 2016, based on data from the Hospital Morbidity Database, the health care database (SIARS) of the Regional Health Administration of Lisbon and Tagus Valley including real-world data from primary care, the 2014 National Health Interview Survey, and expert opinion. Results: The total cost of atherosclerosis in 2016 reached 1.9 billion euros (58% and 42% of which was direct and indirect costs, respectively). Most of the direct costs were associated with primary care (55%), followed by hospital outpatient care (27%) and hospitalizations (18%). Indirect costs were mainly driven by early exit from the labor force (91%). Conclusions: Atherosclerosis has a major economic impact, being responsible for health expenditure equivalent to 1% of Portuguese gross domestic product and 11% of current health expenditure in 2016. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|